Investor Resources. Back; FAQ · Information Requests · IR Contact. Investor Relations. Corporate Profile. Lantheus provides innovative diagnostics, targeted ...
Missing: pgnx | Show results with:pgnx
Oct 2, 2019 · Source: Lantheus Holdings, Inc. and Progenics Pharmaceuticals, Inc. Lantheus Holdings Investor Contact: Mark Kinarney 978-671-8001 ir@lantheus.
progenics pharmaceuticals announces fourth quarter and full ...
www.sec.gov › data › prog20200311_425
(Nasdaq:PGNX) today announced financial results ... Investor Relations at Lantheus Holdings or Progenics as described above. ... Information on or accessed through ...
NASDAQ | LNTH (Common Stock). Data provided by Nasdaq. Minimum 15 minutes delayed. Visit Investor Site. Receive Email Alerts. Join us to change lives. Looking ...
The Investor Relations website contains information about MacroGenics, Inc.'s business for stockholders, potential investors, and financial analysts.
Missing: pgnx | Show results with:pgnx
Jun 22, 2020 · Investor Resources. Back; FAQ · Information Requests ... (“Progenics”) (Nasdaq: PGNX), an oncology ... Senior Director, Investor Relations 978-671 ...
Contact: Investors: Amy Martini Corporate Affairs (914) 789-2816 amartini@progenics. 2011-09-15, EX-99.1. PROGENICS PHARMACEUTICALS ANNOUNCES STRATEGIC FOCUS ON ...
Feb 20, 2020 · PGNX. The Nasdaq stock Market. Indicate by ... If such Progenics stock option is an in-the-money Progenics stock ... Investor Relations at Progenics ...
People also ask
Who owns Progenics Pharmaceuticals?
What does Lantheus Holdings Inc do?
What are the products of progenics?
Where is lantheus located?
Investors may want to look at some small-cap pharma names that could be takeover targets like Relypsa. RLYPARDXSNY · MARKETS. Jul 21 ...
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) institutional ownership structure shows current positions in the company by institutions and funds, as well as ...